26 sep 25   reckitt benckiser gp - 2025 share buyback programme – second tranche reckitt benckiser group plc | rkt | 5,588 0 0.0% | mkt cap: 37,782m    rns number : 8935a reckitt benckiser group plc 26 september 2025   26 september 2025   reckitt benckiser group plc   2025 share buyback programme - second tranche   on 24 july 2025, reckitt benckiser group plc ("reckitt" or the "company") announced its latest £1 billion 2025 share buyback programme (the "programme") to complete over the next 12 months, the purpose of which is to increase returns to shareholders and to reduce the share capital of reckitt.  on 28 july 2025, reckitt announced the details  of a first tranche of the programme to return up to £250 million of capital to shareholders (the "first tranche").   in accordance with the company's general authority to make market purchases of existing ordinary shares of 10 pence each in the share capital of the company (the "ordinary shares") as granted by shareholders at the company's annual general meeting on 8 may 2025, the company will purchase no more than 68,400,000 ordinary shares.   reckitt today announces its intention to commence a second tranche of the programme (the "second tranche") which will return a further £250m of capital to shareholders, to begin on the day following completion of the first tranche (anticipated being during october 2025) and which is expected to end no later than 30 january 2026. all shares repurchased under the second tranche will be held in treasury until completion of the second tranche at which time they will be cancelled.   reckitt announces that it has entered into an agreement with bnp paribas under which it has issued an instruction to bnp paribas to manage the second tranche of the programme.  bnp paribas will, acting as riskless principal, purchase ordinary shares for an aggregate purchase price of no greater than £250 million and will simultaneously sell such ordinary shares on to the company.   any purchase of ordinary shares in relation to this announcement will be carried out on the london stock exchange and multilateral trading facilities, as defined by the directive 2014/65/eu on markets in financial instruments (including the delegated and implementing acts adopted under it) as implemented, retained, amended, extended, re-enacted or otherwise given effect in the united kingdom from 1 january 2021 and as amended or supplemented in the united kingdom thereafter, and executed in accordance with the listing rules and reckitt's general authority to make market purchases of ordinary shares. the shares will be purchased in accordance with the price and volume conditions set out in the commission delegated regulation (eu) 2016/1052 of 8 march 2016 supplementing regulation (eu) no 596/2014 of the european parliament and of the council with regard to regulatory technical standards for the conditions applicable to buyback programmes and stabilisation measures as implemented, retained, amended, extended, re-enacted or otherwise given effect in the united kingdom from 1 january 2021 and as amended or supplemented in the united kingdom thereafter.   reckitt will announce any market repurchase of ordinary shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred. to the extent permitted by law, ordinary shares purchased under the first tranche of the programme will be held in treasury until completion of the secon tranche at which time they will be cancelled. for the avoidance of doubt, no repurchases will be made in respect of the company's american depository receipts.   any further tranches of the programme, which may be conducted after completion of this second tranche, will be announced in due course.   this announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.   for further information:   catheryn o'rourke company secretary   tel +44 (0) 1753 217 800     nick ashworth investor relations director   tel. +44 (0) 7408 812350     about reckitt*:    we make the products people trust to care for the ones they love. we are home to some of the world's best-loved consumer health and hygiene brands, including dettol, durex, finish, gaviscon, harpic, lysol, mucinex, nurofen, strepsils, vanish and veet. consumers are at the heart of everything we do. by creating innovative, science-backed solutions, we support people every day to live healthier lives.   reckitt exists to protect, heal and nurture in the pursuit of a cleaner, healthier world. this commitment goes beyond the products we make. through our actions, we expand access to healthcare, education and economic opportunities. we support the planet by reducing waste, conserving resources and driving sustainable innovation.   we believe good health starts at home. with every action we take, we strive to make our consumers' lives easier, cleaner and healthier, to strengthen communities and to create a more sustainable future.   * reckitt is the trading name of the reckitt benckiser group of companies   reckitt benckiser group plc's lei code is 5493003jfsmojg48v108             this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   mscqelfleklbbbq return to news summary

Label: Neutral